Alamar Biosciences, Inc. (ALMR)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ALMR
See up to 3 months of ALMR. The 7-day demo opens the 1M and 3M ranges and puts ALMR on your watchlist.
Start 7-day demoLatest ALMR insider trades
About Alamar Biosciences, Inc. (ALMR)
Alamar Biosciences, Inc. is an SEC registrant, filing under CIK 0002104204, classified as laboratory analytical instruments. It is grouped with Health Care companies on this site. Its offering priced on 17 April 2026 and it trades on NASDAQ.
ALMR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 4 | 145,285 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ALMR insider transactions (Form 4)
12411 Form 4 filings on record, the earliest from Apr 21, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John L. Brottem - Officer | Grant or award | Common Stock | 29,000 | $0.00 | - | |
| John L. Brottem - Officer | Grant or award | Employee Stock Option (right to buy) | 85,000 | $0.00 | - | |
| Robert P. Ragusa - Director | Grant or award | Common Stock | 5,686 | $0.00 | - | |
| Robert P. Ragusa - Director | Grant or award | Stock Option (Right to Buy) | 25,599 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 185,163 | - footnote F1,F2 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 185,163 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 6,881,410 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 6,881,410 | - footnote F1,F2 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 1,605,645 | - footnote F1 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 1,605,645 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 1,922,329 | - footnote F1 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Class B Common Stock | 1,922,329 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Common Stock | 185,163 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Common Stock | 6,881,410 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Common Stock | 1,605,645 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Common Stock | 1,922,329 | - footnote F7 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series A-3 Preferred Stock | 172,328 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series A-3 Preferred Stock | 6,404,332 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series A-4 Preferred Stock | 154,425 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series A-4 Preferred Stock | 5,738,971 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series B Preferred Stock | 113,625 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series B Preferred Stock | 4,222,738 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series C Preferred Stock | 3,882,451 | $0.00 | - | |
| Qiming Corporate GP VI, Ltd. | Other | Series C Preferred Stock | 4,648,194 | $0.00 | - | |
| ||||||
| Illumina Innovation Fund II GP, L.L.C. | Other | Class B Common Stock | 4,588,364 | - footnote F1 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Class B Common Stock | 922,152 | - footnote F3 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Class B Common Stock | 5,510,516 | - footnote F4 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Common Stock | 5,510,516 | - footnote F4 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Common Stock | 346,020 | - footnote F5 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Common Stock | 271,782 | - footnote F5 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Open-market purchase | Common Stock | 235,294 | $17.00 | $4.00M | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Series A-3 Preferred Stock | 3,194,377 | $0.00 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Series A-4 Preferred Stock | 2,862,507 | $0.00 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Series B Preferred Stock | 2,094,266 | $0.00 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Series C Preferred Stock | 5,037,783 | $0.00 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| Illumina Innovation Fund II GP, L.L.C. | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| ||||||
 Rebecca Chambers | Other | Stock Option (Right to Buy) | 140,612 | $0.00 | - | |
| Rebecca Chambers | Other | Stock Option (Right to Buy) | 140,612 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 49,627 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 49,627 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 33,085 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 33,085 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 124,069 | $0.00 | - | |
| Frank Witney | Other | Stock Option (Right to Buy) | 124,069 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Class B Common Stock | 454,583 | - footnote F1 | - | |
| Timothy Ogden White - Officer | Other | Common Stock | 454,583 | - footnote F1 | - | |
| Timothy Ogden White - Officer | Grant or award | Common Stock | 37,220 | $0.00 | - | |
| Timothy Ogden White - Officer | Grant or award | Stock Option (Right to Buy) | 163,358 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 29,357 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 29,357 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 8,726 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 8,726 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 10,686 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 10,686 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 206,782 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 206,782 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 8,532 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 8,532 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 5,775 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 5,775 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 16,333 | $0.00 | - | |
| Timothy Ogden White - Officer | Other | Stock Option (Right to Buy) | 16,333 | $0.00 | - | |
| ||||||
| Shiping Chen - Officer | Other | Class B Common Stock | 722,885 | - footnote F3 | - | |
| Shiping Chen - Officer | Other | Common Stock | 722,885 | $0.00 | - | |
| Shiping Chen - Officer | Grant or award | Common Stock | 37,220 | $0.00 | - | |
| Shiping Chen - Officer | Grant or award | Stock Option (Right to Buy) | 163,358 | $0.00 | - | |
| Shiping Chen - Officer | Other | Class A Common Stock | 247,311 | $0.00 | - | |
| Shiping Chen - Officer | Other | Founders Preferred Stock | 73,200 | $0.00 | - | |
| Shiping Chen - Officer | Other | Series A-1 Preferred Stock | 176,160 | $0.00 | - | |
| Shiping Chen - Officer | Other | Stock Option (Right to Buy) | 300,883 | $0.00 | - | |
| Shiping Chen - Officer | Other | Stock Option (Right to Buy) | 300,883 | $0.00 | - | |
| Shiping Chen - Officer | Other | Stock Option (Right to Buy) | 12,190 | $0.00 | - | |
| Shiping Chen - Officer | Other | Stock Option (Right to Buy) | 12,190 | $0.00 | - | |
| Shiping Chen - Officer | Other | Class B Common Stock | 320,511 | - footnote F1 | - | |
| Shiping Chen - Officer | Other | Class B Common Stock | 72,853 | - footnote F2 | - | |
| ||||||
| Yuling Luo - Officer | Other | Class B Common Stock | 1,386,746 | - footnote F1 | - | |
| Yuling Luo - Officer | Other | Class B Common Stock | 364,268 | - footnote F2 | - | |
| Yuling Luo - Officer | Other | Class B Common Stock | 1,864,065 | - footnote F3 | - | |
| Yuling Luo - Officer | Other | Common Stock | 1,864,065 | - footnote F3 | - | |
| Yuling Luo - Officer | Grant or award | Common Stock | 76,509 | $0.00 | - | |
| Yuling Luo - Officer | Other | Class B Common Stock | 1,224,152 | - footnote F1 | - | |
| Yuling Luo - Officer | Other | Class B Common Stock | 1,224,152 | - footnote F3 | - | |
| Yuling Luo - Officer | Other | Common Stock | 1,224,152 | - footnote F3 | - | |
| Yuling Luo - Officer | Grant or award | Stock Option (Right to Buy) | 341,191 | $0.00 | - | |
| Yuling Luo - Officer | Other | Class A Common Stock | 1,020,742 | $0.00 | - | |
| Yuling Luo - Officer | Other | Founders Preferred Stock | 366,004 | $0.00 | - | |
| Yuling Luo - Officer | Other | Series A-1 Preferred Stock | 880,802 | $0.00 | - | |
| Yuling Luo - Officer | Other | Class A Common Stock | 1,224,152 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 266,311 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 266,311 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 25,310 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 25,310 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 23,986 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 23,986 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 20,023 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 20,023 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 27,700 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 27,700 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 1,033,912 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 1,033,912 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 37,086 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 37,086 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option (Right to Buy) | 42,334 | $0.00 | - | |
| Yuling Luo - Officer | Other | Stock Option ((Right to Buy) | 42,334 | $0.00 | - | |
| ||||||
 Justin J. McAnear - Officer | Grant or award | Common Stock | 37,220 | $0.00 | - | |
| Justin J. McAnear - Officer | Grant or award | Stock Option (Right to Buy) | 163,358 | $0.00 | - | |
| Justin J. McAnear - Officer | Other | Stock Option (Right to Buy) | 570,719 | $0.00 | - | |
| Justin J. McAnear - Officer | Other | Stock Option (Right to Buy) | 570,719 | $0.00 | - | |
| Nicholas Naclerio | Other | Class B Common Stock | 4,588,364 | - footnote F1 | - | |
| Nicholas Naclerio | Other | Class B Common Stock | 922,152 | - footnote F3 | - | |
| Nicholas Naclerio | Other | Class B Common Stock | 5,510,516 | - footnote F4 | - | |
| Nicholas Naclerio | Other | Common Stock | 5,510,516 | - footnote F4 | - | |
| Nicholas Naclerio | Other | Common Stock | 346,020 | - footnote F5 | - | |
| Nicholas Naclerio | Other | Common Stock | 271,782 | - footnote F5 | - | |
| Nicholas Naclerio | Open-market purchase | Common Stock | 235,294 | $17.00 | $4.00M | |
| Nicholas Naclerio | Grant or award | Common Stock | 5,686 | $0.00 | - | |
| Nicholas Naclerio | Grant or award | Stock Option (Right to Buy) | 25,599 | $0.00 | - | |
| Nicholas Naclerio | Other | Series A-3 Preferred Stock | 3,194,377 | $0.00 | - | |
| Nicholas Naclerio | Other | Series A-4 Preferred Stock | 2,862,507 | $0.00 | - | |
| Nicholas Naclerio | Other | Series B Preferred Stock | 2,094,266 | $0.00 | - | |
| Nicholas Naclerio | Other | Series C Preferred Stock | 5,037,783 | $0.00 | - | |
| Nicholas Naclerio | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| Nicholas Naclerio | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| ||||||
Item 5.02
Item 2.02, 9.01
Item 8.01
Item 2.02, 9.01
Recent ALMR Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Qiming Managing Directors Fund VI, L.P. | Affiliate | 41,945 | $987K | View on EDGAR |
ALMR insider trading FAQ
What is the latest insider trade for ALMR?
Alamar Biosciences, Inc. (ALMR) had 2 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for ALMR runs to 11 Form 4 filings, the earliest from 2026-04-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALMR stock?
No insider purchases of ALMR were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling ALMR stock?
No insider sales of ALMR were filed in the last 90 days.
Where can I see ALMR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALMR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John L. Brottem view on EDGAR
- - Robert P. Ragusa view on EDGAR
- - Qiming Corporate GP VI, Ltd. view on EDGAR
- - Illumina Innovation Fund II GP, L.L.C. view on EDGAR
- - Rebecca Chambers view on EDGAR
- - Frank Witney view on EDGAR
- - Timothy Ogden White view on EDGAR
- - Shiping Chen view on EDGAR
- - Yuling Luo view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ALMR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALMR with a 7-day demo
- ALMR on your watchlist
- Every ALMR Form 4 filing on record
- Up to 3 months of ALMR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
